Emergent BioSolutions, Inc. (NYSE:EBS)
CAPS Rating:
A biopharmaceutical company focused on the development, manufacture and commercialization of immunobiotics. The Company operates in two business segments: biodefense and commercial.
RSS Headlines
Fool UK
Recs
Sadly, bioterrorism and biowarfare will be a threat for quite awhile.